Deepika Kanojia
Singapore, 117599, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Correction: Shyamsunder et al. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. Int. J. Mol. Sci. 2022, 23, 1207.
Journal: International journal of molecular sciences
Published: May 20, 2026
Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.
Journal: Scientific reports
Published: December 15, 2025
Retraction Note: Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.
Journal: Journal of hematology & oncology
Published: November 28, 2025
Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
Journal: Pharmacological research
Published: June 30, 2022
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors.
Journal: International journal of molecular sciences
Published: December 15, 2021
Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas.
Journal: Cellular and molecular life sciences : CMLS
Published: May 05, 2020
TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Journal: Gastroenterology
Published: August 01, 2019
Identification of somatic alterations in lipoma using whole exome sequencing.
Journal: Scientific reports
Published: May 31, 2019
Identification of a novel enhancer of CEBPE essential for granulocytic differentiation.
Journal: Blood
Published: November 15, 2018
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma.
Journal: Nature communications
Published: August 15, 2018
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
Journal: Nature communications
Published: January 07, 2018
Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets.
Journal: Journal of hematology & oncology
Published: July 13, 2017
Last Updated: 09/26/2026